Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Stock Information | RedChip

Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Listen to this Section


$6.35
+0.2900 ( +4.79% ) 23.1K

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Market Data


Open


$6.35

Previous close


$6.06

Volume


23.1K

Market cap


$242.83M

Day range


$6.02 - $6.52

52 week range


$4.22 - $11.69

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Mar 28, 2024
3 Insider transactions 2 Mar 28, 2024
10-k Annual reports 130 Mar 27, 2024
8-k 8K-related 38 Mar 07, 2024
5 Other 1 Feb 14, 2024
8-k 8K-related 13 Nov 28, 2023
8-k 8K-related 35 Nov 14, 2023
10-q Quarterly Reports 89 Nov 13, 2023
8-k 8K-related 34 Oct 10, 2023
3 Insider transactions 2 Sep 29, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.